2012-03-27T12:54:26-05:00 2011-06-30 BDO USA LLP 100 PARK AVENUE NEW YORK NY 10017 990 2010-07-01 131673104 NATIONAL KIDNEY FOUNDATION INC NATI 2128892210 30 EAST 33RD STREET NEW YORK NY 10016 BRUCE SKYER 2012-03-22 true Paul Hammerschmidt 2128858000 2010 2016-02-24 21:20:13Z BRUCE SKYER 30 EAST 33RD STREET NEW YORK NY 10016 62608919 false X WWW.KIDNEY.ORG X 1950 NY TO PREVENT KIDNEY AND URINARY TRACT DISEASES, IMPROVE THE HEALTH AND WELL-BEING OF INDIVIDUALS AND FAMILIES AFFECTED BY THESE DISEASES, AND INCREASE THE AVAILABILITY OF ALL ORGANS FOR TRANSPLANTATION. 31 30 563 20000 0 0 29176465 27779768 15462449 18818497 -1129269 -657057 2630746 2296880 46140391 48238088 4775640 3750987 0 0 21241556 24120957 995431 228526 4899961 25509082 22467911 52521709 50568381 -6381318 -2330293 21269550 23274999 16291776 19340824 4977774 3934175 X NATIONAL KIDNEY FOUNDATION'S MISSION IS TO PREVENT KIDNEY AND URINARY TRACT DISEASES, IMPROVE THE HEALTH AND WELL-BEING OF INDIVIDUALS AND FAMILIES AFFECTED BY THESE DISEASES, AND INCREASE THE AVAILABILITY OF ALL ORGANS FOR TRANSPLANTATION. THE ORGANIZATION CONDUCTS NATIONWIDE EDUCATIONAL CAMPAIGNS ABOUT THE ROLE OF THE KIDNEY IN MAINTAINING OVERALL HEALTH, THE IMPORTANCE OF EARLY DETECTION AND ORGAN DONATION AND TRANSPLANTATION. false false 12010501 3222 5737800 COMMUNITY SERVICES AND ASSISTANCE TO AFFILIATES - THE ORGANIZATION'S KIDNEY EARLY EVALUATION PROGRAM (KEEP) SCREENS INDIVIDUALS MOST AT RISK OF POTENTIAL MEDICAL CONDITIONS THAT MAY LEAD TO FUTURE KIDNEY DISEASE. MORE THAN 1,250 PEOPLE WITH HIGH BLOOD PRESSURE, DIABETES OR A FAMILY HISTORY OF KIDNEY DISEASE PARTICIPATE IN THIS FREE KIDNEY DISEASE SCREENING PROGRAM EVERY MONTH IN CITIES AROUND THE U.S. AS A RESULT, MANY LEARNED THAT THEY HAD EARLY KIDNEY DAMAGE AND BEGAN TAKING STEPS TO SAVE THEIR HEALTH, INCLUDING MONITORING BLOOD PRESSURE AND BLOOD GLUCOSE LEVELS, CHANGING THEIR DIET AND MEDICATION. ASSISTANCE IS PROVIDED BY THE ORGANIZATION TO ITS AFFILIATES. THE ORGANIZATION PROVIDES CONSULTATION, GUIDANCE, TRAINING AND LEADERSHIP. SPECIFIC GUIDANCE IS PROVIDED WITH INSTRUCTION BOOKLETS DEALING WITH PATIENT TRANSPORTATION PROGRAMS, DRUG & BLOOD BANKS AND SCREENING AND DETECTION PROGRAMS. AFFILIATES ARE KEPT UP TO DATE WITH CURRENT PUBLICATIONS FROM THE ORGANIZATION. 11217607 195387 8657696 PROFESSIONAL EDUCATION - THE ORGANIZATION OFFERS MULTIDISCIPLINARY PROGRAMS TO THE ENTIRE KIDNEY HEALTH CARE TEAM. THERE ARE NATIONAL MEETINGS OFFERING A WIDE RANGE OF TOPICS AS WELL AS FOCUSED LOCAL/REGIONAL SEMINARS. THE SPRING CLINICAL NEPHROLOGY MEETING HAS GROWN INTO THE NEPHROLOGY COMMUNITY'S PREMIER LEARNING EXPERIENCE WITH OVER 3,000 IN ATTENDANCE. A RECORD 300 POSTERS WERE PRESENTED, AND THIS MEETING ALSO SAW THE HIGHEST-EVER PARTICIPATION IN THE INTERNAL MEDICINE AND PEDIATRIC TRAINEES PROGRAM. AN ADVANCED PRACTITIONER PROGRAM TRACK WAS INTRODUCED, DESIGNED SPECIFICALLY FOR PHYSICIAN ASSISTANTS AND NURSE PRACTITIONERS, A GROUP THAT IS NOW CARING FOR KIDNEY PATIENTS ON THE FRONT LINES. SINCE 1981, THE ORGANIZTAION HAS PUBLISHED PEER-REVIEWED JOURNALS THAT PROVIDE TIMELY INSIGHTS AND INFORMATION ON KIDNEY DISEASE RESEARCH TO THE GLOBAL KIDNEY COMMUNITY. THIS YEAR, THREE OF THE PRESTIGIOUS MEDICAL JOURNALS PUBLISHED BY THE ORGANIZATION JOINED SCIENCEDIRECT, THE PREMIER WEB DISTRIBUTOR OF PROFESSIONAL LEVEL SCIENTIFIC AND MEDICAL INFORMATION. WITH MORE THAN 11 MILLION USERS ACCESSING THE SITE, THE JOURNALS REACHED A LARGER AUDIENCE THAN EVER BEFORE. THE ORGANIZATION'S KIDNEY LEARNING SYSTEM PROGRAM CONTINUED TO PROVIDE COMPREHENSIVE EDUCATION ABOUT CHRONIC KIDNEY DISEASE (CKD) AND HOW TO PREVENT, TREAT AND MANAGE COMPLICATIONS. NEW RESOURCES DEVELOPED IN 2011 FOCUSED ON IDENTIFYING AND MANAGING RISK FOR KIDNEY DISEASE, AND TREATING ALL STAGES OF CKD. 7159656 54864 2068102 PUBLIC HEALTH EDUCATION - ATTRACTING 5,250,000 VISITORS IN 2011, THE ORGANIZATION'S WEBSITE, WWW.KIDNEY.ORG, CONTINUED TO EDUCATE AND SERVE AS A RICH RESOURCE ON KIDNEY DISEASE. MEDICAL INFORMATION SEEKERS FLOODED OUR A-Z HEALTH GUIDE PAGES FOR COMPREHENSIVE DATA ON A VARIETY OF KIDNEY CONDITIONS AND ISSUES, INCLUDING NUTRITION AND TREATMENT OPTIONS. MORE THAN 7,000 TESTED THEIR KIDNEY IQ WITH OUR ONLINE KIDNEY QUIZ. E-KIDNEY, THE ORGANIZATION'S MONTHLY E-NEWSLETTER, OFFERED NEWS, KIDNEY-HEALTHY RECIPES AND STORIES OF COURAGE TO NEARLY 180,000 PEOPLE. E-KIDNEY READERSHIP ROSE 40% THIS YEAR. KIDNEY NEWS DAILY, A DAILY E-NEWSLETTER, DELIVERED BREAKING NEWS FROM THE PRINT, BROADCAST AND ONLINE MEDIA TO THOUSANDS IN THE KIDNEY CARE COMMUNITY. THE ORGANIZATION CONTINUES TO FOCUS ON EDUCATING GROUPS WITH HIGH RISK OF KIDNEY DISEASE. NEARLY HALF OF AFRICAN AMERICANS HAVE AT LEAST ONE RISK FACTOR FOR KIDNEY DISEASE, BUT LESS THAN 3% BELIEVE THAT CHRONIC KIDNEY DISEASE IS A "TOP HEALTH CONCERN", ACCORDING TO A REPORT RELEASED THIS YEAR IN THE AMERICAN JOURNAL OF KIDNEY DISEASES, THE OFFICIAL NKF JOURNAL. SINCE AFRICAN AMERICANS WITH CKD PROGRESS MORE QUICKLY TO KIDNEY FAILURE, THE ORGANIZATION DOUBLED ITS EFFORTS TO REACH OUT TO THIS GROUP WITH INFORMATION AND FREE SCREENINGS HELD IN CHURCHES, SCHOOLS AND COMMUNITY CENTERS IN AFRICAN-AMERICAN NEIGHBORHOODS. 8874396 3497514 1518979 39262160 true false false true false false false false true true false false true false true false true false false false false false true true false false false true true false false false false false false false false true false false false false true false false false false true 448 0 true 563 true false false false false false true true false false false true false X 31 30 false false false false false false false true true false true true true true true true true true true true false AL AK AZ AR CA CO CT DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY X X PETROS GREGORIOU 2128892210 30 EAST 33RD STREET NEW YORK NY 10016 X JOHN R DAVIS 35.0 X X 395145 0 212449 WILLIAM CELLA 2.0 X X 0 0 0 ED WALTER 2.0 X X 0 0 0 THOMAS P MCDONOUGH 2.0 X X 0 0 0 LYNDA A SZCZECH MD MSCE 2.0 X X 0 0 0 BETH PIRAINO MD 2.0 X X 0 0 0 BRYAN N BECKER MD 2.0 X X 0 0 0 ALLAN COLLINS THRU 10312010 1.0 X X 0 0 0 KEN HOWARD 1.0 X X 0 0 0 WILLIAM G DESSOFFY CFA 2.0 X X 0 0 0 DEBORAH BROMMAGE THRU 10312010 1.0 X X 0 0 0 JOSEPH D ABRUZZESE 1.0 X 0 0 0 GEORGE L BAKRIS MD 1.0 X 0 0 0 RD TODD BAUR 1.0 X 0 0 0 A BRUCE BOWDEN ESQ 2.0 X 0 0 0 DEREK E BRUCE ESQ 1.0 X 0 0 0 ALEXANDER M CAPRON PHD 1.0 X 0 0 0 JAMES G CARLSON 1.0 X 0 0 0 PAUL CRAWFORD MD 1.0 X 0 0 0 JANE S DAVIS CRNP 1.0 X 0 0 0 THOMAS M DAVIS III 1.0 X 0 0 0 FRANCIS L DELMONICO MD 1.0 X 0 0 0 BRIAN DILSHEIMER 1.0 X 0 0 0 JAY JUSTICE 1.0 X 0 0 0 JOHN KIRKENDALL 1.0 X 0 0 0 DENNIS W MORGAN 1.0 X 0 0 0 HOWARD M NATHAN 1.0 X 0 0 0 SISTER MICHELE O'BRIEN MSN 1.0 X 0 0 0 STEPHEN PASTAN MD 1.0 X 0 0 0 RONALD RITTENMEYER THRU 142011 1.0 X 0 0 0 GUY L SCALZI 1.0 X 0 0 0 GREGORY W SCOTT 1.0 X 0 0 0 MICHAEL W SEXTON 1.0 X 0 0 0 MICHAEL WATTS CPA 1.0 X 0 0 0 PETROS A GREGORIOU 35.0 X 150887 0 20101 THOMAS M MARTIN THRU 4292011 35.0 X 237883 0 48647 DOLPH CHIANCHIANO 35.0 X 233717 0 20664 JOSEPH VASSALOTTI 35.0 X 255122 0 30963 GISELE POLITOSKI 35.0 X 259404 0 41902 KERRY WILLIS 35.0 X 203998 0 31519 JOAN SHEPARD LUSTIG 35.0 X 208356 0 18111 JOANN VECCHIONE 35.0 X 185726 0 37934 PRESTON ENGLERT JR 35.0 X 256971 0 26849 INGRID MONTECINO 35.0 X 209566 0 11634 LAWRENCE GEIGER 35.0 X 171991 0 21512 BETH IRICK 35.0 X 157225 0 9918 HOLLY DEVAN 35.0 X 155522 0 21325 3081513 0 553528 20 false true false TUFTS MEDICAL CENTER 800 WASHINGTON STREET BOX 453 BOSTON MA 02111 GUIDELINES DEVELOP. 354840 MINNEAPOLIS MEDICAL RESEARCH 914 SOUTH 8TH STREET SHAPIRO BLDG MINNEAPOLIS MN 55404 CKD SCREENINGS 327208 QUEST DIAGNOSTICS PO BOX 12989 CHICAGO IL 60693 MEDICAL TESTING 310013 MEDSCAPE LLC 12186 COLLECTIONS CENTER DRIVE CHICAGO IL 60693 EDUCATIONAL SERVICES 272500 BERYL PO BOX 678052 DALLAS TX 75267 CALL CENTER 248875 16 716151 11363343 15700274 5355117 27779768 KEEP GRANTS AND CONTRACT REVENUE 621990 3679350 3679350 GRANT AND CONTRACT REVENUE 611600 1387762 1387762 SPONSORSHIPS 611600 2195110 2195110 THRIFT STORE REVENUE 448000 1021321 1021321 REGISTRATION FEES 611600 739043 739043 9795911 9795911 18818497 224290 224290 0 2111479 2111479 6164076 5343467 5833038 6555852 331038 -1212385 -881347 -881347 1663141 11363343 1663141 0 0 266285 318800 -52515 -52515 MISCELLANEOUS REVENUE 611710 237916 237916 237916 48238088 17982577 2475743 0 3750987 3750987 0 0 2663477 1908247 554394 200836 0 17468689 13511875 3376044 580770 641591 486181 155410 2026348 1735221 262854 28273 1320852 954580 308815 57457 0 30842 22967 6640 1235 70107 50666 16391 3050 42028 42028 228526 228526 41400 41400 5017384 4340257 189995 487132 1813073 1013498 32383 767192 4097231 3534376 402192 160663 803264 708360 79721 15183 6573 5438 299 836 2541775 1841952 586339 113484 2543781 2216640 142531 184610 0 3852954 2199933 37975 1615046 55129 39842 12889 2398 0 250908 181331 58662 10915 316967 216701 53603 46663 PRIZE EXPENSE 292890 72373 1230 219287 DUES AND SUBSCRIPTIONS 80066 59708 12240 8118 TAXES 40917 3035 982 36900 MISCELLANEOUS 570622 365964 73271 131387 50568381 39262160 6406260 4899961 5650 6200 2208975 3860332 2864138 1506229 517702 616304 559806 327103 1042589 686983 2441542 1961156 670919 480386 10426175 11287267 2973596 4504195 21269550 23274999 8437664 10390217 7854112 5450607 3500000 16291776 19340824 X -8248746 -8674678 11875562 11257895 1350958 1350958 4977774 3934175 21269550 23274999 X -2330293 1286694 X false true true X false X 12858895 15127948 23570061 28044857 27779768 107381529 12858895 15127948 23570061 28044857 27779768 107381529 107381529 2192525 2405401 2082885 2156806 2335769 11173386 212130 246367 458497 119013412 80986730 0.90226 0.88626 X 6588 35440 42028 45626392 45668420 1000000 250000 1000000 1000000 1000000 1000000 4000000 6000000 173244 472593 232895 42028 920760 250000 250000 250000 250000 1000000 1500000 26382 15000 31078 6588 79048 9387737 65973 1824600 1393168 9885142 8830253 667192 854414 964122 9387737 11926721 381012 -2992846 484634 8830253 0.13670 0.86330 true false 264964 138230 126734 255162 147999 107163 1921416 1674927 246489 480386 DUE FROM AFFILIATES 3695876 REMAINDER TRUSTS & ESTATES 733450 OTHER ASSETS 74869 4504195 0 0 48238088 50568381 -2330293 1286694 -1711987 -425293 -2755586 51156699 1286694 69447 1578870 2935011 48221688 16400 16400 48238088 53912285 69447 3290857 3360304 50551981 16400 16400 50568381 PART V, LINE 4: THE ORGANIZATION'S PERMANENTLY RESTRICTED ENDOWMENT CONSISTS OF PERMANENTLY RESTRICTED NET ASSETS HELD PRIMARILY FOR RESEARCH AND PATIENT SUPPORT. THE REMAINING PORTION OF THE DONOR-RESTRICTED ENDOWMENT FUND THAT IS NOT CLASSIFIED IN PERMANENTLY RESTRICTED NET ASSETS IS CLASSIFIED AS TEMPORARILY RESTRICTED NET ASSETS UNTIL THOSE AMOUNTS ARE EXPENDED AND RELEASED FROM RESTRICTIONS. PART X, LINE 2: THE ORGANIZATION HAS NOT TAKEN AN UNCERTAIN TAX POSITION THAT WOULD REQUIRE PROVISION OF A LIABILITY UNDER ASC 740, "INCOME TAXES". UNDER ASC 740, AN ORGANIZATION MUST RECOGNIZE THE TAX BENEFIT ASSOCIATED WITH TAX POSITIONS TAKEN FOR TAX RETURN PURPOSES WHEN IT IS MORE LIKELY THAN NOT THAT THE POSITION WILL BE SUSTAINED. THE ORGANIZATION DOES NOT BELIEVE THERE ARE ANY MATERIAL UNCERTAIN TAX POSITIONS AND, ACCORDINGLY, HAS NOT RECOGNIZED ANY LIABILITY FOR UNRECOGNIZED TAX BENEFITS. THE ORGANIZATION HAS FILED IRS FORM 990, AS REQUIRED, AND ALL OTHER APPLICABLE RETURNS IN JURISDICTIONS WHEN IT IS REQUIRED. FOR THE YEAR ENDED JUNE 30, 2011, THERE WERE NO INTEREST OR PENALTIES RECORDED OR INCLUDED IN THE CONSOLIDATED FINANCIAL STATEMENTS. PART XI, LINE 8: NET DEFICIT ON RELATED ORGANIZATIONS, CAMP REYNAL AND KIDNEY DISEASE IMPROVING GLOBAL OUTCOMES. PART XII, LINE 2D: REVENUES OF RELATED ORGANIZATIONS, CAMP REYNAL AND KIDNEY DISEASE IMPROVING GLOBAL OUTCOMES, IN THE AMOUNT OF $1,260,070, AND COST OF GOODS SOLD IN THE AMOUNT OF $318,800. PART XIII, LINE 2D: EXPENSES OF RELATED ORGANIZATIONS, CAMP REYNAL AND KIDNEY DISEASE IMPROVING GLOBAL OUTCOMES, IN THE AMOUNT OF $2,972,057, AND COST OF GOODS SOLD IN THE AMOUNT OF $318,800. X X X X X X true ADESA IMPACT KIDNEY CARS PROGRAM true 4663975 228526 4435449 4663975 228526 4435449 AL AR CA CO CT DC FL GA IL KS ME MD MA MI MN MS MO NH NJ NM NY NC OH OK OR PA RI SC TN UT VA WA WV WI CHILI COOKOFF 1121479 1121479 5000 39325 -44325 GALA 928483 588483 340000 106931 0 233069 150 10976522 9653381 1323141 107182 476004 739955 13026484 11363343 1663141 219113 515329 928699 1663141 true PATIENT ASSISTANCE GRANTS 2126 1308658 RESEARCH FELLOWSHIP GRANTS 32 1296748 YOUNG INVESTIGATOR RESEARCH GRANTS 9 850000 TRAVEL GRANTS TO KIDNEY PATIENTS 297 201492 SCHOLARSHIPS TO KIDNEY PATIENTS 11 73314 PROFESSIONAL COUNCIL RESEARCH GRANTS 5 20775 PART I, LINE 2: THE ORGANIZATION'S MOST SIGNIFICANT GRANTS ARE FOR NEPHROLOGY RESEARCH AND INCLUDE CLINICAL SCIENTIST GRANTS, YOUNG INVESTIGATOR GRANTS, RESEARCH FELLOWSHIP GRANTS, AND PROFESSIONAL COUNCIL GRANTS. THE ORGANIZATION HAS ESTABLISHED A RESEARCH AWARD COMMITTEE TO REVIEW APPLICATIONS AND SELECT RESEARCH FELLOWS ON AN ANNUAL BASIS. THE ORGANIZATION CLOSELY MONITORS THE USE OF GRANT FUNDS. EACH AWARDEE IS REQUIRED TO SUBMIT AN ANNUAL PROGRESS REPORT. EACH ADDITIONAL YEAR OF FUNDING IS CONTINGENT UPON APPROVAL AND REVIEW OF THE ANNUAL PROGRESS REPORT AND AVAILABILITY OF FUNDS. UPON COMPLETION OF THE LAST YEAR OF THE GRANT, A FINAL REPORT MUST BE SUBMITTED BY THE AWARDEE. THE ORGANIZATION ALSO PROVIDES GRANTS, SCHOLARSHIPS AND PATIENT ASSISTANCE TO PERSONS WITH KIDNEY DISEASE. X X X X X false true false false false false false false false JOHN R DAVIS 395145 0 0 0 0 0 174486 0 37963 607594 0 DOLPH CHIANCHIANO 233717 0 0 0 0 0 5867 0 14797 254381 0 PETROS A GREGORIOU 150887 0 0 0 0 0 1817 0 18284 0 170988 0 THOMAS M MARTIN THRU 4292011 237883 0 0 0 0 0 17440 0 31207 0 286530 0 JOSEPH VASSALOTTI 255122 0 0 0 0 0 12679 0 18284 0 286085 0 GISELE POLITOSKI 259404 0 0 0 0 0 21137 0 20765 0 301306 0 KERRY WILLIS 203998 0 0 0 0 0 8833 0 22686 0 235517 0 JOAN SHEPARD LUSTIG 208356 0 0 0 0 0 12291 0 5820 0 226467 0 JOANN VECCHIONE 185726 0 0 0 0 0 16256 0 21678 0 223660 0 PRESTON ENGLERT JR 256971 0 0 0 0 0 8565 0 18284 0 283820 0 INGRID MONTECINO 209566 0 0 0 0 0 3969 0 7665 0 221200 0 LAWRENCE GEIGER 171991 0 0 0 0 0 3228 0 18284 0 193503 0 BETH IRICK 157225 0 0 0 0 0 2253 0 7665 0 167143 0 HOLLY DEVAN 155522 0 0 0 0 0 3041 0 18284 0 176847 0 PART I, LINE 4B: THE ORGANIZATION HAS A SECTION 457(F) SENIOR STAFF FLEXIBLE BENEFIT PLAN THAT PROVIDES SENIOR MANAGEMENT EMPLOYEES WITH A BENEFIT ALLOWANCE CONTRIBUTED BY THE ORGANIZATION, WHICH CAN BE USED FOR VARIOUS BENEFIT OPTIONS, INCLUDING A CAPITAL ACCUMULATION ACCOUNT. IN ADDITION, JOHN R. DAVIS, CEO, PARTICIPATES IN A SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN. X 6826 5343467 FAIR MARKET VALUE X 9 1190 FAIR MARKET VALUE X SUPPLIES 3 10460 FAIR MARKET VALUE false true true PART I, LINE 32B: THE ORGANIZATION CONTRACTS WITH ADESA IMPACT TO ADVERTISE FOR THE DONATION OF VEHICLES AND TO RECEIVE AND DISPOSE OF THE DONATED VEHICLES ON BEHALF OF THE ORGANIZATION. THE ORGANIZATION USED THE NUMBER OF ITEMS CONTRIBUTED FOR CARS AND VEHICLES. FORM 990, PART III, LINE 4D: 1) PATIENT SERVICES - INCLUDE PROGRAMS WHICH PROVIDE MEDICAL JEWELRY, EMERGENCY GRANTS, TRANSPORTATION, SUPPORT GROUPS AND WORKSHOPS FOR KIDNEY PATIENTS. OTHER PROGRAMS INCLUDE PATIENT EDUCATION, CONSTITUENT COUNCIL PROJECTS AND PATIENT EMPOWERMENT INITIATIVES. TO HELP KIDNEY PATIENTS IMPACTED BY NATURAL DISASTERS, THE ORGANIZATION ESTABLISHED A FINANCIAL ASSISTANCE PROGRAM THAT OFFERS SUPPORT AND ENSURES MEDICAL CARE IS NOT COMPROMISED. FUNDS COVERS THE COST OF TRAVEL TO DIALYSIS CENTERS AS WELL AS REPLACEMENT OF DAMAGED POSSESSIONS, HOMES AND BASIC NECESSITIES SUCH AS GROCERIES AND CLOTHING. BEYOND THE MATERIAL SUPPORT, THE ORGANIZATION IS THERE TO HELP KIDNEY PATIENTS COPE WITH THE TRAUMA EXPERIENCED. HUNDREDS OF DIALYSIS PATIENTS TOOK PART IN "PEOPLE LIKE US" STEPPING BACK INTO LIFE, A PROGRAM THAT HELPED THEM DEAL WITH DEPRESSION AND ANXIETY. PARTICIPANTS REPORTED IMPROVEMENTS IN STRESS LEVELS, SOCIAL FUNCTIONING AND OVERALL HEALTH AFTER COMPLETING STEPPING BACK INTO LIFE. EXPENSES: $5,440,834. GRANTS: $1,311,159. REVENUE: $1,506,732. 2) RESEARCH - RESEARCH REPRESENTS ONE OF THE ORGANIZATION'S TOP PRIORITIES. THE ORGANIZATION GRANTED OVER 60 RESEARCH GRANTS DURING FISCAL YEAR 2011. RESEARCH PROJECTS INCLUDE IMPROVING TRANSPLANT MEDICATIONS, RESEARCHING CARDIOVASCULAR DISEASE AND KIDNEY DISEASE, FINDING THE CAUSE OF DIABETIC NEPHROPATHY, AND IMPROVING THE DIALYSIS PROCESS. RESEARCH IS BEING CONDUCTED ON HOW TO MINIMIZE THE CHANCES OF ORGAN REJECTION OVER A LONG PERIOD OF TIME. THE ULTIMATE OBJECTIVE OF THIS RESEARCH IS TO CREATE IMPROVED TRANSPLANT MEDICATIONS THAT SPECIFICALLY TARGET CELLS RESPONSIBLE FOR ORGAN REJECTION, THEREBY ENSURING MORE SUCCESSFUL LONG-TERM SURVIVAL OF THE TRANSPLANTED ORGAN. CARDIOVASCULAR DISEASE, ESPECIALLY HEART FAILURE, IS THE LEADING CAUSE OF DEATH FOR KIDNEY PATIENTS. SOME RESEARCH IN THIS AREA IS LOOKING AT HOW VITAMIN D AND THE IMMUNE SYSTEM ARE RELATED TO CARDIOVASCULAR DISEASE IN KIDNEY PATIENTS. THIS STUDY MAY LEAD TO SPECIFIC THERAPEUTIC INTERVENTIONS THAT TARGET INNATE IMMUNE RESPONSES TO PREVENT DAMAGE TO THE VASCULAR SYSTEM. DIABETIC NEPHROPATHY (DN), A SERIOUS AND LIFE-THREATENING PROGRESSIVE KIDENY DISEASE, IS THE MOST COMMON CAUSE OF KIDNEY FAILURE IN THE U.S. DISCOVERING THE MECHANISM BEHIND DN IS THE GOAL OF SOME RESEARCHERS. WITH A BETTER UNDERSTANDING OF WHAT TRIGGERS DN, THERAPEUTIC REGIMENS AIMED AT KIDNEY CELL RESTORATION CAN BE CREATED, WHICH WOULD BE BENEFICIAL FOR PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES. IN THE AREA OF DIALYSIS, THE ORGANIZATION RESEARCHERS HOPE TO FIND SOME ANSWERS ON HOW TO MORE EFFICIENTLY REMOVE PROTEIN-BOUND CHEMICALS THEREBY IMPROVING DIALYSIS ITSELF. OTHER GRANTS ASSISTED THE TRAINING OF YOUNG PHYSICIANS (YOUNG INVESTIGATORS) WHO CONDUCTED THE STUDIES. WITH A ROBUST RESEARCH PROGRAM, IMPROVED TREATMENTS FOR CHRONIC KIDNEY DISEASE, MORE SUCCESSFUL TRANSPLANTS AND ADDITIONAL METHODS OF EARLY DETECTION AND PREVENTION MAY BE ON THE HORIZON IN THE NEAR FUTURE. EXPENSES: $3,433,562. GRANTS: $2,186,355. REVENUE: $12,247. FORM 990, PART VI, SECTION B, LINE 11B: THE ORGANIZATION'S BOARD OF DIRECTORS ASSIGNS THE AUDIT COMMITTEE THE OVERSIGHT RESPONSIBILITY OF THE IRS FORM 990 AND ITS SUPPLEMENTAL SCHEDULES. FORM 990 IS REVIEWED BY THE CHIEF EXECUTIVE OFFICER, CHIEF FINANCIAL OFFICER, AND AUDIT COMMITTEE PRIOR TO FILING. THE FINAL AND SIGNED FORM 990 IS MADE AVAILABLE TO THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 12C: TO IDENTIFY CONFLICTS OF INTEREST, OFFICERS, DIRECTORS (GOVERNING BOARD MEMBERS) AND SENIOR STAFF MUST ANNUALLY DISCLOSE ANY POTENTIAL CONFLICTS OF INTEREST. THE ORGANIZATION'S AUDIT COMMITTEE AND THE COMPLIANCE OFFICER MANAGES THE DISCLOSURE AND MONITORING PROCESSES RELATED TO POTENTIAL CONFLICTS OF INTEREST. EACH PERSON ALSO HAS THE RESPONSIBILITY TO REPORT HIS OR HER OWN CONFLICTS OF INTEREST, WHETHER ACTUAL OR PERCEIVED, WHEN SUCH CONFLICTS ARISE DURING A MEETING. AFTER DISCLOSURE OF THE MATERIAL FACTS, THE INDIVIDUAL SHALL LEAVE THE BOARD OR COMMITTEE MEETING WHILE THE POTENTIAL CONFLICT OF INTEREST IS DISCUSSED AND DETERMINED. THE DISCLOSURE, DECISIONS MADE, AND ACTIONS TAKEN ARE DOCUMENTED IN THE MINUTES OF THE MEETING. FORM 990, PART VI, SECTION B, LINE 15A: THE COMPENSATION COMMITTEE IS RESPONSIBLE FOR ESTABLISHING GUIDELINES AND APPROVING COMPENSATION FOR THE CHIEF EXECUTIVE OFFICER ON AN ANNUAL BASIS. THE COMPENSATION COMMITTEE USES AN INDEPENDENT CONSULTANT AND COMPENSATION BENCHMARK STUDIES TO DETERMINE COMPENSATION FOR THE CHIEF EXECUTIVE OFFICER. FORM 990, PART VI, SECTION B, LINE 15B: THE COMPENSATION COMMITTEE IS RESPONSIBLE FOR ESTABLISHING GUIDELINES AND APPROVING COMPENSATION FOR SENIOR MANAGEMENT POSITIONS ON AN ANNUAL BASIS. THE COMPENSATION COMMITTEE USES AN INDEPENDENT CONSULTANT AND COMPENSATION BENCHMARK STUDIES TO DETERMINE COMPENSATION FOR SENIOR MANAGEMENT. THE CHIEF EXECUTIVE OFFICER IS RESPONSIBLE FOR THE INDIVIDUAL PERFORMANCE EVALUATIONS OF SENIOR MANAGEMENT AND DETERMINES MERIT INCREASES AND/OR BONUSES WITHIN GUIDELINES ESTABLISHED BY THE COMPENSATION COMMITTEE. FORM 990, PART VI, SECTION C, LINE 19: THE ORGANIZATION MAKES CERTAIN GOVERNING DOCUMENTS AVAILABLE TO THE PUBLIC THROUGH ITS WEBSITE, WWW.KIDNEY.ORG. SUCH DOCUMENTS INCLUDE THE AUDITED FINANCIAL STATEMENTS, ANNUAL REPORTS, CONFLICT OF INTEREST POLICY, IRS DETERMINATION LETTER AND THE MOST RECENT FORM 990. OTHER GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST TO THE COMPLIANCE OFFICER. FORM 990, PART XI, LINE 5: NET UNREALIZED GAINS ON INVESTMENTS CAMP REYNAL INC 5429 LBJ FREEWAY SUITE 250 DALLAS TX 75240 061738038 CHILDREN CAMP TX 501(C)(3) 7 KDIGO PATIENT CARE BE N/A N/A false true false true false false false false false false true false true true false false false true KDIGO B 1753727 KDIGO K 1260069 KDIGO M 75000 KDIGO N 809499 KDIGO R 31499